Quantcast Flu Vaccine Surplus Highlights Lack Of Communication
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Flu Vaccine Surplus Highlights Lack Of Communication

Posted on 03/21/2007 20:03:54 | Link | Post Comment
by Mark S. Senak
Eye On FDA



Associated Press reports yesterday that on midnight of June 30, the expiration date will pass for millions of doses of flu vaccine that went unused this year and they will accordingly be destroyed. I can't help wondering how that happens - do they just dump it down the drain? Is it set on fire? Where does it go? If anyone knows, I would love to know the answer.

But the destruction of this batch of flu vaccine raises some other, more serious questions. First is, why can't the number of flu vaccines match the number of people who want them? It seems a terrible waste of money and resources when these numbers don't match. One need only cast back into time a short while, when the Chiron manufacturing facility in the United Kingdom was closed by British medical authorities and the resulting shortage in the United States of flu vaccine caused canceled vaccination programs by employers and schools, and saw the elderly waiting in long lines with lawn chairs just so that they could get a vaccination. The year before that, the AP article states, Wyeth (WYE) had to destroy one-third of its supply in 2002-2003 at a staggering cost. Now a few years later, the fish are getting the leftovers.

One reason for a surplus one year and a shortage another has to do with hiccups in the manufacturing process and a lack of ability to predict the exact number of doses that are going to be available in any given year. That process is beyond my scope, but the need for better coordination is obvious.

But I do think one aspect to the problem is one involving communications. The Associated Press article cites the fact that demand this year was down. There is an opportunity for flu manufacturers and/or government to engage communications in putting together a social marketing campaign that does some credible research into what motivates people to get flu vaccines and what keeps them from coming in - and then to develop campaigns and messaging that do what a social marketing campaign does that advertising cannot do - change people's behavior. Speaking for myself, I have never in my life had a flu vaccination. What messages would motivate people to get the vaccine, even late in the season when it appears that supply will hold out? It is naive at best to believe that banners announcing flu vaccinations alone will drive the audience to act and all sides win if there is a greater understanding that matches the supply with marketplace behavior.


Source: EyeOnFDA.com



RELATED READING:
- FDA Failing to Acknowledge Image Problems
- FDA Cuts Women Health Budgeting
- New FDA Commisioner Silent Since Taking Helm
____________________
Stock Quote or
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Fri Jul 18, 2008 08:23AM
U.S. stock futures rebound on Citigroup results"S&a [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.